+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
From
Ophthalmic Drugs Market Report 2024-2034 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2024-2034

  • Report
  • October 2023
  • 284 Pages
  • Global
From
From
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 140 Pages
  • Global
From
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 667 Pages
  • Global
From
From
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 816 Pages
  • Global
From
From
Immunology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 450 Pages
  • Global
From
Loading Indicator